GBS Patho physiology

Reading File

Finding Sources

Searching PubMed

"Guillain-Barre syndrome"[MeSH Terms] AND pathophysiology

Reading File

Finding Sources

Reading File

I now have comprehensive material to write a detailed, well-organized answer. Let me compile everything.

Guillain-Barré Syndrome (GBS) - Pathophysiology

Overview

GBS is an organ-specific, immune-mediated disorder of the peripheral nervous system caused by a synergistic interaction of cell-mediated and humoral immune responses directed against peripheral nerve antigens. It is the most common cause of acute flaccid paralysis in the post-polio era, with an annual incidence of 1-2 per 100,000.

1. Trigger: Preceding Infections (Molecular Mimicry)

~65-70% of patients report a preceding illness 1-4 weeks before neurological onset. The key mechanism is molecular mimicry - the immune system attacks peripheral nerve antigens because they structurally resemble microbial antigens.

Common triggers:

Antecedent Event	% of Cases
Respiratory illness	58%
Gastrointestinal illness	22%
Both respiratory + GI	10%
Surgery	5%
Vaccination	3%

Key infectious agents:

Campylobacter jejuni - the most important; found in 17-39% of GBS cases in the West and up to 76% of AMAN cases in northern China. The HS:O19 serotype generates lipooligosaccharide (LOS) that shares GM1 ganglioside-like epitopes with axonal membranes.
Cytomegalovirus (CMV)
Epstein-Barr virus (EBV)
Zika virus (significantly increased risk - French Polynesia, Colombia, Puerto Rico)
HIV, varicella-zoster, Mycoplasma pneumoniae, Hepatitis A/B, H. influenzae
SARS-CoV-2 (modest association; pandemic paradoxically decreased GBS incidence due to fewer communicable infections)

Only ~1 in 1,000 people infected with C. jejuni develops GBS, indicating that host genetic factors (HLA polymorphisms, etc.) also determine susceptibility.

2. Immune Mechanisms - AIDP (Demyelinating Form)

AIDP is the most common subtype in North America and Europe (~97% of cases).

Step-by-step immunopathogenesis:

Step 1 - T cell sensitization: Antigen-presenting cells present microbial antigens that mimic peripheral nerve myelin proteins (e.g., P0, P2, PMP22). Autoreactive T cells are activated in lymphoid tissue.

Step 2 - Blood-nerve barrier disruption: Activated T cells cross the blood-nerve barrier (which is relatively leaky at nerve roots and ganglia) into the endoneurium. Pro-inflammatory cytokines (TNF-α, IL-1, IL-6, IFN-γ) are released, further disrupting the barrier.

Step 3 - Humoral attack on Schwann cells: Autoantibodies target myelin-associated glycoprotein (MAG), GM1, GD1a, and other gangliosides on the Schwann cell membrane. Complement activation is central:

C3d and membrane attack complex (C5b-9) deposit on the outermost Schwann cell membrane
This triggers vesicular myelin changes (myelin blistering and disintegration)

Step 4 - Macrophage-mediated demyelination: Complement deposition recruits macrophages (M1 phenotype). Macrophages physically strip off myelin lamellae from the axon in a process called "myelinophagy." This is the primary effector mechanism of demyelination.

Step 5 - Conduction failure: Segmental demyelination at nodes of Ranvier causes:

Loss of saltatory conduction
Conduction block (even without structural axon damage, explaining reversibility)
Reduced conduction velocities

Step 6 - Secondary axonal degeneration: Severe or prolonged inflammation leads to a "bystander" toxic effect on axons, causing Wallerian-like degeneration. This is the basis for poor recovery in severe AIDP.

The inflammatory infiltrates consist mainly of:

Class II MHC-positive monocytes and macrophages
T lymphocytes (both CD4+ and CD8+)
Schwann cells upregulate MHC class II, potentially presenting antigen directly to autoreactive T cells

3. Immune Mechanisms - AMAN (Axonal Form)

AMAN (Acute Motor Axonal Neuropathy) is predominant in northern China, Japan, and parts of South America.

Key mechanism - GM1 ganglioside molecular mimicry:

![AMAN pathogenesis diagram](molecular mimicry in AMAN)

C. jejuni LOS contains GM1-like oligosaccharide epitopes
Infection generates anti-GM1 IgG antibodies (also anti-GD1a)
These antibodies bind to GM1 gangliosides at the nodes of Ranvier on motor axons
Complement activation (C3d and C5b-9) occurs directly at the axolemma
Macrophages enter the periaxonal space (between axon and innermost myelin lamella) and cause axonal injury without significant demyelination
Nodal elongation and paranodal myelin retraction occur
Reversible conduction failure in mild cases (antibodies cleared, node regenerates)
Wallerian-like axonal degeneration in severe cases, leading to prolonged or incomplete recovery

AMAN is exclusively motor because GM1 is expressed predominantly on motor nerve fibers.

4. AMSAN (Acute Motor-Sensory Axonal Neuropathy)

Antibodies target both GM1 and GD1a on motor AND sensory fibers
Extensive primary Wallerian-like degeneration of motor and sensory roots/nerves
No significant inflammation or demyelination
Most severe subtype with worst recovery

5. Miller Fisher Syndrome (MFS) Variant

Anti-GQ1b IgG antibodies (found in >90% of MFS cases)
GQ1b is enriched in paranodal myelin of cranial nerves III, IV, VI, and muscle spindles
Classic triad: ophthalmoplegia, ataxia, areflexia (no limb weakness)
GQ1b is also present at neuromuscular junctions, explaining areflexia

6. Why Nerve Roots Are Preferentially Targeted

The blood-nerve barrier is least developed at the nerve roots (dorsal root ganglia and proximal motor roots)
This makes roots the point of easiest immune access
Most lesions occur on ventral roots, proximal spinal nerves, and lower cranial nerves
This explains the ascending, proximal-predominant pattern of weakness

7. Key Pathological Changes Summary

Feature	AIDP	AMAN	AMSAN
Primary target	Myelin/Schwann cell	Motor axon (node of Ranvier)	Motor + sensory axon
Mechanism	T cell + complement + macrophage	Anti-GM1/GD1a + complement	Anti-GM1/GD1a + complement
Histology	Perivascular lymphocytes, demyelination, macrophage myelinophagy	Periaxonal macrophages, no demyelination	Wallerian degeneration, minimal inflammation
Conduction studies	Slow conduction velocities, conduction block	Normal/low-amplitude CMAPs	Low amplitude CMAPs, normal velocity
Recovery	Usually good	Good (if mild)	Prolonged/incomplete

8. Why Reflexes Are Lost (Areflexia)

Muscle spindle afferents (Ia fibers) are large, heavily myelinated sensory fibers. Demyelination or axonal injury disrupts the afferent limb of the stretch reflex arc, causing areflexia even when voluntary motor strength may still be partially preserved. This is often one of the earliest signs.

9. Autonomic Involvement

~65% of GBS patients have autonomic dysfunction. Autonomic nerve fibers and ganglia are attacked by the same immune mechanisms, leading to:

Cardiac arrhythmias (tachy- or bradycardia)
Blood pressure instability (hyper/hypotension)
Ileus, urinary retention
Anhidrosis
The most life-threatening complication of GBS is autonomic dysregulation causing cardiac arrest

10. Cytoalbuminous Dissociation (CSF finding)

A hallmark finding: elevated CSF protein with <10 cells/µL.

Proteins leak into CSF because inflammation damages the blood-nerve barrier at the intrathecal nerve roots
Despite intense immune infiltration, the meninges are not primarily involved, so pleocytosis is absent
This dissociation appears ~1-2 weeks after symptom onset (may be normal in first week)

Summary Diagram of Pathophysiology

Preceding infection (C. jejuni, CMV, Zika, etc.)
            ↓
   Molecular mimicry
            ↓
  Autoreactive T cells + Autoantibodies
            ↓
   ┌─────────────────────────────────┐
   │ AIDP                  │ AMAN   │
   │ Complement + Macrophages attack │ Anti-GM1 IgG + complement │
   │ Schwann cell myelin   │ axolemma at node of Ranvier │
   │ → Segmental demyelination       │ → Periaxonal macrophages │
   └─────────────────────────────────┘
            ↓
   Conduction block / failure
            ↓
  Ascending flaccid paralysis + Areflexia + Autonomic dysfunction

Key Sources:

Bradley and Daroff's Neurology in Clinical Practice, Ch. 106 (Pathogenesis, p. 2663-2668)
Robbins & Kumar Basic Pathology, Ch. 20 (p. 809)
Goldman-Cecil Medicine, Pathobiology of GBS

Hi! How can I help you today?

This is a shared conversation. Sign in to Orris to start your own chat.